Intact Vascular, Inc.

Intact Vascular, Inc. specializes in developing innovative vascular solutions aimed at improving patient outcomes in interventional procedures through advanced technologies and precise treatment tools. Founded in 2011 and headquartered in Wayne, US, Intact Vascular, Inc. is focused on pioneering unique solutions for vascular interventions.

The company was acquired by Koninklijke Philips N. V. in August 2020 for approximately USD 360. 00 mn, a deal that included an upfront cash consideration of USD 275 mn and deferred payments totaling USD 85 mn.

Their operations have been streamlined to align with Philips’ expansive healthcare technology offerings, without any mention of prior pivots or subsidiaries. Philips' Vascular Suite provides a comprehensive array of advanced solutions designed to enhance vascular procedure efficiency and outcomes. This suite includes products for peripheral, aortic, visceral, arterial, and venous interventions, featuring cutting-edge imaging technologies and specialized tools aimed at restoring vessel patency and addressing aneurysms. These products are intended for use by healthcare professionals in interventional settings, ensuring real-time guidance and decision-making support, primarily serving hospitals and healthcare providers across North America, Europe, and Asia-Pacific.

Philips generates revenue through direct sales and strategic partnerships within the healthcare sector, focused on B2B transactions. Revenue channels encompass sales of advanced imaging systems and interventional tools, often bundled into comprehensive packages. Philips Capital provides financing solutions, which facilitate healthcare organizations' access to innovative technologies while allowing for structured payment plans. The Vascular Suite's flagship products tailored for peripheral arterial and aortic disease interventions significantly contribute to the company’s financial performance, complemented by extensive support and training services.

Moving forward, Intact Vascular, Inc. aims to leverage the resources from its acquisition by Koninklijke Philips N. V. to enhance its product development pipeline.

The company plans to introduce new innovative products aimed at improving vascular intervention outcomes, with specific release dates to be announced. Expansion efforts will target emerging markets in Asia and South America by 2023, seeking to establish a stronger presence in these regions. The recent funding will be utilized to bolster R&D and marketing efforts, ensuring that the new offerings are effectively integrated and promoted within Philips' existing healthcare solutions.